HERPES SIMPLEX VIRUS TYPE 1 & 2 QUALITATIVE PCR - SERUM

Herpes Simplex Virus (HSV) Type 1 & 2 Qualitative PCR - Serum is an advanced molecular diagnostic test used to detect the presence of Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2) DNA in serum samples. The test utilizes highly sensitive Polymerase Chain Reaction (PCR) technology to identify active herpes virus infection by detecting viral genetic material directly in the bloodstream.

HSV-1 is commonly associated with oral herpes, while HSV-2 is more frequently linked to genital herpes. In certain individuals, especially newborns, immunocompromised patients, and those with disseminated infections, the virus may spread into the bloodstream and cause serious systemic disease. Early molecular detection supports timely diagnosis and treatment.

Benefits of the Test

• Highly sensitive detection of HSV-1 and HSV-2 DNA.
• Provides rapid confirmation of active herpes infection.
• Differentiates between HSV Type 1 and Type 2.
• Detects viral DNA directly in serum.
• Supports early diagnosis of systemic HSV infection.
• Useful in high-risk and immunocompromised patients.
• Provides reliable molecular diagnostic results.
• Supports timely antiviral treatment decisions.

Why Doctors Recommend This Test

Doctors recommend HSV Type 1 & 2 Qualitative PCR Serum testing for patients with suspected systemic herpes infection, neonatal herpes, severe HSV disease, immunocompromised conditions, unexplained viral illness, or when direct molecular confirmation of HSV infection is required.

The test helps identify active viral infection and supports prompt clinical management and antiviral therapy.

Preparation Before Test

• No fasting is generally required.
• A blood sample is collected and processed to obtain serum.
• Inform your doctor about current antiviral medications.
• Provide relevant medical and infection history.
• Follow all sample collection instructions carefully.
• Ensure timely transport of the specimen to the laboratory.

Normal Reporting Time

Most Herpes Simplex Virus Type 1 & 2 Qualitative PCR - Serum reports at Focus Diagnostics are available within 2–3 hours for specimen processing and molecular workflow initiation. Final PCR analysis, validation, and reporting are generally completed within a few working days depending on laboratory protocols and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Individuals with suspected systemic HSV infection.
• Patients with severe herpes virus disease.
• Newborns suspected of neonatal herpes.
• Immunocompromised individuals.
• Patients with unexplained viral symptoms.
• Individuals requiring molecular confirmation of HSV infection.
• Organ transplant recipients.
• Patients undergoing infectious disease evaluation.

Detailed Information

Herpes Simplex Virus infections are among the most common viral infections worldwide. HSV-1 and HSV-2 can cause localized disease involving the oral cavity, skin, genital region, eyes, and nervous system. In certain situations, especially when immunity is weakened, the virus may spread beyond its primary site and enter the bloodstream.

Detection of HSV DNA in serum may indicate active viral replication and systemic dissemination. This can be particularly important in neonates, transplant recipients, cancer patients, individuals living with HIV/AIDS, and other immunocompromised patients who are at increased risk of severe HSV disease.

Qualitative PCR directly detects viral genetic material and is considered one of the most sensitive methods available for diagnosing active herpes virus infection. Unlike antibody testing, which reflects the body's immune response, PCR confirms the actual presence of viral DNA in the specimen being tested.

The test can detect HSV DNA even when viral concentrations are low, making it highly valuable in early infection and in cases where rapid diagnosis is essential. Early identification allows healthcare providers to initiate antiviral treatment promptly and reduce the risk of complications.

Serum PCR testing may be used alongside lesion PCR testing, cerebrospinal fluid analysis, serological testing, and clinical evaluation depending on the patient's symptoms and medical condition. Comprehensive assessment helps ensure accurate diagnosis and optimal management.

Results should always be interpreted together with clinical findings, imaging studies, laboratory investigations, and physician evaluation. Additional testing may be recommended depending on the patient's presentation and risk factors.

At Focus Diagnostics, Herpes Simplex Virus Type 1 & 2 Qualitative PCR Serum testing is performed using advanced molecular diagnostic platforms, validated PCR methodologies, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful infectious disease diagnostic results.